Free Trial

ReposiTrak Inc. (NYSE:TRAK) CEO Randall K. Fields Sells 2,500 Shares

ReposiTrak logo with Computer and Technology background

ReposiTrak Inc. (NYSE:TRAK - Get Free Report) CEO Randall K. Fields sold 2,500 shares of the firm's stock in a transaction on Monday, June 23rd. The shares were sold at an average price of $20.05, for a total transaction of $50,125.00. Following the completion of the transaction, the chief executive officer now directly owns 167,000 shares of the company's stock, valued at $3,348,350. This represents a 1.47% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

ReposiTrak Stock Down 2.1%

Shares of TRAK stock traded down $0.40 on Wednesday, reaching $19.04. The stock had a trading volume of 58,618 shares, compared to its average volume of 43,838. ReposiTrak Inc. has a 12 month low of $14.23 and a 12 month high of $25.01. The stock has a market cap of $348.05 million, a price-to-earnings ratio of 57.18 and a beta of 0.54. The company has a debt-to-equity ratio of 0.01, a quick ratio of 6.03 and a current ratio of 6.03.

ReposiTrak Cuts Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, August 14th. Shareholders of record on Monday, June 30th will be paid a $0.0182 dividend. The ex-dividend date is Monday, June 30th. This represents a $0.07 annualized dividend and a yield of 0.38%. ReposiTrak's dividend payout ratio is 20.59%.

Institutional Trading of ReposiTrak

A hedge fund recently raised its stake in ReposiTrak stock. Ellsworth Advisors LLC boosted its holdings in ReposiTrak Inc. (NYSE:TRAK - Free Report) by 10.6% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 31,289 shares of the company's stock after acquiring an additional 2,997 shares during the period. Ellsworth Advisors LLC owned 0.17% of ReposiTrak worth $634,000 as of its most recent filing with the Securities and Exchange Commission. 27.35% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Separately, Wall Street Zen raised shares of ReposiTrak from a "hold" rating to a "buy" rating in a research report on Thursday, May 22nd.

View Our Latest Report on TRAK

About ReposiTrak

(Get Free Report)

Park City Group, Inc, a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers.

Read More

Insider Buying and Selling by Quarter for ReposiTrak (NYSE:TRAK)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in ReposiTrak Right Now?

Before you consider ReposiTrak, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ReposiTrak wasn't on the list.

While ReposiTrak currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Next Palantir? AI-Defense Stock Set for Explosive Growth
2 Chip Stocks Are Soaring—But One Could Break Out This Summer
Congress Bought This Stock at the Bottom—Will You Miss It?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines